Domain Therapeutics Bags €39M to Block GPCRs in Cancer Immunotherapy
Domain Therapeutics, a biopharmaceutical company in France and Canada developing cancer immunotherapies targeting G protein-coupled…
13/05/2022 - 4 minutes
Checkpoint Inhibitors
GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos
Analysts are abuzz over GSK’s co-development deal with immuno-oncology specialist iTeos Therapeutics earlier this month,…
30/06/2021 - 5 minutes
BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel…
29/04/2021 - 5 minutes
Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy
The French company OSE Immunotherapeutics has signed a partnership to use artificial intelligence to develop…
27/03/2019 - 2 minutes
Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold
A combination cancer immunotherapy from French biotech Innate Pharma was twice as effective at treating…
22/10/2018 - 2 minutes
Replimune’s €85M IPO set to Boost Oncolytic Immunotherapy Pipeline
The US-UK biotech completed its $100M (€85M) IPO on the NASDAQ stock exchange to further…
26/07/2018 - 2 minutes
Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”
Known for curing US President Jimmy Carter’s cancer, Keytruda continues to benefit many other cancer…
24/07/2018 - 6 minutes
Massive Series B Funding Could Bring Belgian Immuno-oncology Treatments Into the Clinic
iTeos Therapeutics raised €65M ($75M) to bring two of its cancer treatments into the clinic…
20/06/2018 - 2 minutes
Genmab and Janssen Suffer Combination Therapy Setback
Janssen will discontinue a Phase I study testing Danish biotech Genmab's blood cancer blockbuster daratumumab…
28/05/2018 - 2 minutes
Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?
Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much…
09/04/2018 - 4 minutes
Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech
OSE Immunotherapeutics could receive up to €1.1Bn from its new partner Boehringer Ingelheim, which has…
05/04/2018 - 2 minutes
Danish Biotech Collaborates With US Merck on Combination Therapy for Lung Cancer
IO Biotech will test its immune modulator in combination with Merck’s checkpoint inhibitor Keytruda, known…
13/03/2018 - 2 minutes
